Alnylam Pharmaceuticals, Inc. (ALNY) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)

FMR LLC and Abigail P. Johnson filed an amended Schedule 13G reporting ownership of common stock of Alnylam Pharmaceuticals, Inc. as of September 30, 2026. The filing indicates beneficial ownership of 12,675,052.96 shares.